UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 54

Sortiert nach

In vitro MR imaging of regulated gene expression

Radiology, 2003-08, Vol.228 (2), p.488

2003

Volltextzugriff (PDF)

Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth

Clinical & experimental metastasis, 2002-01, Vol.19 (2), p.155-160

2002

Volltextzugriff (PDF)

Pleiotrophin can be rate-limiting for pancreatic cancer cell growth

Cancer research (Chicago, Ill.), 2000-09, Vol.60 (18), p.5284-5288

2000

Volltextzugriff (PDF)

An FGF‐binding protein (FGF‐BP) exerts its biological function by parallel paracrine stimulation of tumor cell and endothelial cell proliferation through FGF‐2 release

International journal of cancer, 2001-05, Vol.92 (4), p.510-517

2001

Volltextzugriff (PDF)

HER-2/neu Is Rate-limiting for Ovarian Cancer Growth

The Journal of biological chemistry, 1997-11, Vol.272 (47), p.29482-29486

1997

Volltextzugriff (PDF)

Enhanced Antitumorigenic Effects in Glioblastoma on Double Targeting of Pleiotrophin and Its Receptor ALK1

Neoplasia (New York, N.Y.), 2009-02, Vol.11 (2), p.145-156

2009

Volltextzugriff (PDF)

Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation

Oncogene, 2001-04, Vol.20 (17), p.2101-2111

2001

Volltextzugriff (PDF)

Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivo

Oncogene, 2002-08, Vol.21 (37), p.5733-5742

2002

Volltextzugriff (PDF)

Heregulin-β1 regulates the estrogen receptor-α gene expression and activity via the ErbB2/PI 3-K/akt pathway

Oncogene, 2003-04, Vol.22 (14), p.2073-2087

2003

Volltextzugriff (PDF)

Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors

The Journal of biological chemistry, 1994-11, Vol.269 (45), p.28243-28248

1994

Volltextzugriff (PDF)

Immunolocalization of an FGF-binding protein reveals a widespread expression pattern during different stages of mouse embryo development

Histochemistry and cell biology, 2002-01, Vol.117 (1), p.1-11

2002

Volltextzugriff (PDF)

ERbB‐2 expression is rate‐limiting for epidermal growth factor–mediated stimulation of ovarian cancer cell proliferation

International journal of cancer, 2000-06, Vol.86 (5), p.644-651

2000

Volltextzugriff (PDF)

HER-2/neu is rate-limiting for ovarian cancer growth. Conditional depletion of HER-2/neu by ribozyme targeting

The Journal of biological chemistry, 1997-11, Vol.272 (47), p.29482-29486

1997

Volltextzugriff (PDF)

Inhibition of HER-2 by three independent targeting strategies increases paclitaxel resistance of SKOV-3 ovarian carcinoma cells

Naunyn-Schmiedeberg's archives of pharmacology, 2005-02, Vol.371 (2), p.141-151

2005

Volltextzugriff (PDF)

Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth

The Journal of biological chemistry, 1994-08, Vol.269 (33), p.21358-21363

1994

Volltextzugriff (PDF)

The human papillomavirus (HPV) 16 E6 oncoprotein leads to an increase in gene expression of the angiogenic switch molecule FGF-BP in non-immortalized human keratinocytes

Oncogene, 2001-11, Vol.20 (50), p.7430-7436

2001

Volltextzugriff (PDF)

Das Nadelöhr – von der Forschung zur Entwicklung

Die Pharmaindustrie, 2017, p.53-115

2017

Volltextzugriff (PDF)

Reversal of HER-2 over-expression renders human ovarian cancer cells highly resistant to taxol

Toxicology (Amsterdam), 2000-04, Vol.144 (1), p.221-228

2000

Volltextzugriff (PDF)

Heregulin- 1 regulates the estrogen receptor- gene expression and activity via the ErbB2 PI 3-K Akt pathway

Oncogene, 2005-03, Vol.24 (11), p.1964-1964

2005

Volltextzugriff (PDF)

Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway

Oncogene, 2005-03, Vol.24 (11), p.1964-1964

2005

Volltextzugriff (PDF)

Correction: Heregulin-β1 regulates the estrogen receptor-α gene expression and activity via the ErbB2/PI 3-K/Akt pathway

Oncogene, 2005-03, Vol.24 (11), p.1964-1964

2005

Volltextzugriff (PDF)

Inhibition of fibroblast growth factors

Breast cancer research and treatment, 1996-01, Vol.38 (1), p.109-119

1996

Volltextzugriff (PDF)

Ribozyme-targeting of a secreted FGF-binding protein inhibits proliferation of prostate cancer cells in vitroand in vivo

Oncogene, 2002-08, Vol.21 (37), p.5733

2002

Volltextzugriff (PDF)

Differential Regulation of a Fibroblast Growth Factor-Binding Protein during Skin Carcinogenesis and Wound Healing1

Neoplasia (New York, N.Y.), 2004-09, Vol.6 (5), p.595-602

2004

Volltextzugriff (PDF)

Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway

Oncogene, 2003-04, Vol.22 (14), p.2073-2087

2003

Volltextzugriff (PDF)

26 – 50 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(52)
Buchkapitel
(2)

Sprache

Englisch
(52)
Japanisch
(19)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(39)
Humans
(33)
Animals
(25)
Biological And Medical Sciences
(22)
Mice
(21)
Oncology
(16)
Tumor Cells, Cultured
(15)
Medical Sciences
(14)
Transfection
(13)
Biochemistry & Molecular Biology
(12)
Mice, Nude
(11)
Gene Expression
(10)
Polyethyleneimine - Chemistry
(10)
Female
(9)
Fundamental And Applied Biological Sciences. Psychology
(9)
Pharmacology & Pharmacy
(9)
Rna, Catalytic - Metabolism
(9)
Tumors
(9)
Neoplasm Transplantation
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In vitro MR imaging of regulated gene expression

Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth

Pleiotrophin can be rate-limiting for pancreatic cancer cell growth

An FGF‐binding protein (FGF‐BP) exerts its biological function by parallel paracrine stimulation of tumor cell and endothelial cell proliferation through FGF‐2 release

HER-2/neu Is Rate-limiting for Ovarian Cancer Growth

Enhanced Antitumorigenic Effects in Glioblastoma on Double Targeting of Pleiotrophin and Its Receptor ALK1

Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation

Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivo

Heregulin-β1 regulates the estrogen receptor-α gene expression and activity via the ErbB2/PI 3-K/akt pathway

Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors

Immunolocalization of an FGF-binding protein reveals a widespread expression pattern during different stages of mouse embryo development

ERbB‐2 expression is rate‐limiting for epidermal growth factor–mediated stimulation of ovarian cancer cell proliferation

HER-2/neu is rate-limiting for ovarian cancer growth. Conditional depletion of HER-2/neu by ribozyme targeting

Inhibition of HER-2 by three independent targeting strategies increases paclitaxel resistance of SKOV-3 ovarian carcinoma cells

Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth

The human papillomavirus (HPV) 16 E6 oncoprotein leads to an increase in gene expression of the angiogenic switch molecule FGF-BP in non-immortalized human keratinocytes

Das Nadelöhr – von der Forschung zur Entwicklung

Reversal of HER-2 over-expression renders human ovarian cancer cells highly resistant to taxol

Heregulin- 1 regulates the estrogen receptor- gene expression and activity via the ErbB2 PI 3-K Akt pathway

Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway

Correction: Heregulin-β1 regulates the estrogen receptor-α gene expression and activity via the ErbB2/PI 3-K/Akt pathway

Inhibition of fibroblast growth factors

Ribozyme-targeting of a secreted FGF-binding protein inhibits proliferation of prostate cancer cells in vitroand in vivo

Differential Regulation of a Fibroblast Growth Factor-Binding Protein during Skin Carcinogenesis and Wound Healing1

Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway

Suchergebnisse filtern